Pain Therapeutics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 41,119 10,890 11,484 16,809
Cost of Revenue - - - -
Gross Profit 41,119 10,890 11,484 16,809
Operating Expenses
Research and Development 4,917 7,605 8,300 15,746
Sales, General and Admin. 4,837 7,182 6,698 14,766
Non-Recurring Items - - - -
Other - - - -
Operating Income 31,365 (3,897) (3,514) (13,703)
Income From Continuing Operations
Add'l Income/Expense Items 106 451 901 1,680
Earnings Before Interest and Tax 31,471 (3,446) (2,613) (12,023)
Interest Expense - - - -
Earnings Before Tax 31,471 (3,446) (2,613) (12,023)
Income Tax (73) - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 31,544 (3,446) (2,613) (12,023)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 31,544 (3,446) (2,613) (12,023)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 31,544 (3,446) (2,613) (12,023)